Myasthenia Gravis, Generalized

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360

Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

Multi-Modal Monitoring of Disease Symptoms in Myasthenia Gravis

A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthenia Gravis (MAGIC)

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

Safety And Efficacy Of Tofacitinib In Patients With Refractory Myasthenia Gravis: A Pilot Study

Markers of Favorable Response to Complement Inhibitors Therapy

Rituximab EfFicacy IN MyasthEnia Gravis (REFINE)

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

A Pilot Study to Explore the Role of Gut Flora in Myasthenia Gravis

Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)

Study of Telitacicept in Generalized Myasthenia Gravis

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Efficacy and Safety of Tocilizumab in the Treatment of Generalized Myasthenia Gravis

Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)